跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
M-PRAVASTATIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
M-PRAVASTATIN
Authorized
STANDARD
M-PRAVASTATIN
mantra pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
cf4b13562adbea73
Company
mantra pharma inc
Type
Standard
Approval Details
Approval Id
cf4b13562adbea73
Drug Approval Canada Name
M-PRAVASTATIN
Product Name
M-PRAVASTATIN
Status
Marketed
Status Date
2025-04-16
Original Market Date
2018-12-11
Din
02476282
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
24:06.08
Atc Original
C10AA03 PRAVASTATIN
Atc Name
c 10 aa 03
Aig Number
0122563002
Company Name
mantra pharma inc
Company Address
1000 Rue Du Lux Suite 201, Brossard, Quebec, Canada, J4Y 0E3
Active Ingredients
PRAVASTATIN SODIUM
20 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
cf4b13562adbea73
Type
Standard
Back to Health Canada Approvals